Interestingly, we observed similar patterns among shNgp and shS1008 groups regarding the control of expression of PD-1, 4-1BBL, and CD160 inhibitory molecules with a final increase of those on T cells upon HCC development. This evidence concerns the gene CD160 and hepatocellular carcinoma.